Filing Details
- Accession Number:
- 0001415889-25-016722
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-11 17:32:32
- Reporting Period:
- 2025-06-09
- Filing Date:
- 2025-06-11
- Accepted Time:
- 2025-06-11 17:32:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals International Plc | KNSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1867899 | Eben Tessari | 23 Old Bond Street, Third Floor London X0 W1S 4PZ | Chief Operating Officer | No | No | No | No |
Transaction Summary
| Sold: | 70,867 shares | Avg. Price: $30.48 | Total Value: $2,160,035.40 |
| Number of Shares After Transactions: | 72,363 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Acquisiton | 2025-06-09 | 10,319 | $10.36 | 82,682 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2025-06-09 | 10,319 | $30.38 | 72,363 | No | 4 | S | Direct | |
| Class A Ordinary Share | Acquisiton | 2025-06-10 | 15,506 | $10.36 | 87,869 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2025-06-10 | 15,506 | $30.46 | 72,363 | No | 4 | S | Direct | |
| Class A Ordinary Share | Acquisiton | 2025-06-11 | 45,042 | $10.36 | 117,405 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2025-06-11 | 45,042 | $30.51 | 72,363 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Share Option | Disposition | 2025-06-09 | 10,319 | $0.00 | 10,319 | $10.36 |
| Class A Ordinary Share | Share Option | Disposition | 2025-06-10 | 15,506 | $0.00 | 15,506 | $10.36 |
| Class A Ordinary Share | Share Option | Disposition | 2025-06-11 | 45,042 | $0.00 | 45,042 | $10.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 99,476 | 2028-02-29 | No | 4 | M | Direct | |
| 83,970 | 2028-02-29 | No | 4 | M | Direct | |
| 38,928 | 2028-02-29 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.42. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.64. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.69. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
